中鼻道微环境与鼻息肉发生的研究进展

修倩, 陈曦, 祝子峰, 等. 中鼻道微环境与鼻息肉发生的研究进展[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30(22): 1758-1764. doi: 10.13201/j.issn.1001-1781.2016.22.004
引用本文: 修倩, 陈曦, 祝子峰, 等. 中鼻道微环境与鼻息肉发生的研究进展[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30(22): 1758-1764. doi: 10.13201/j.issn.1001-1781.2016.22.004
XIU Qian, CHEN Xi, ZHU Zifeng, et al. Microenvironment of middle meatus involved in pathogenesis of nasal polyps——the possibility and research progress[J]. J Clin Otorhinolaryngol Head Neck Surg, 2016, 30(22): 1758-1764. doi: 10.13201/j.issn.1001-1781.2016.22.004
Citation: XIU Qian, CHEN Xi, ZHU Zifeng, et al. Microenvironment of middle meatus involved in pathogenesis of nasal polyps——the possibility and research progress[J]. J Clin Otorhinolaryngol Head Neck Surg, 2016, 30(22): 1758-1764. doi: 10.13201/j.issn.1001-1781.2016.22.004

中鼻道微环境与鼻息肉发生的研究进展

  • 基金项目:

    国家自然科学基金资助(No:81500775,No:81170892,No:81371075)

详细信息
    通讯作者: 朱冬冬,E-mail:zhudd@jlu.edu.cn
  • 中图分类号: R765.25

Microenvironment of middle meatus involved in pathogenesis of nasal polyps——the possibility and research progress

More Information
  • 加载中
  • [1]

    MELTZER E O, HAMILOS D L, HADLEY J A,et al. Rhinosinusitis:establishing definitions for clinical research and patient care[J].J Allergy Clin Immunol, 2004,114:155-212.

    [2]

    MATSUNE S, KONO M, SUN D, et al. Hypoxia in paranasal sinuses of patients with chronic sinusitis with or without the complication of nasal allergy[J].Acta Otolaryngol,2003,123:519-523.

    [3]

    JIANG S, DONG Z, ZHU D, et al.Local tissue hypoxia and formation of nasal polyps[J]. Chin Med J (Engl),2003,116:243-247.

    [4]

    EARLY S B, HISE K, HAN J K,et al. Hypoxia stimulates inflammatory and fibrotic responses from nasal-polyp derived fibroblasts[J].Laryngoscope,2007,117:511-515.

    [5]

    COSTE A, BRUGEL L, MAÎTRE B,et al. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor[J]. Eur Respir J,2000,15:367-372.

    [6]

    GOSEPATH J, BRIEGER J, LEHR H A,et al.Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal poly[J]. Am J Rhinol,2005,19:7-13.

    [7]

    SHIN H W, CHO K, KIM D W,et al. Hypoxia-inducible factor 1 mediates nasal polypogenesis by inducing epithelial-to-mesenchymal transition[J]. Am J Respir Crit Care Med,2012,185:944-954.

    [8]

    COHEN S, EFRAIM A N, LEVI-SCHAFFER F,et al.The effect of hypoxia and cycloxygenase inhibitors on nasal polyp derived fibroblasts[J]. Am J Otolaryngol,2011,32:564-573.

    [9]

    JIN J, CHANG D Y, KIM S H,et al.Role of hypoxia-inducible factor-1α expression in regulatory T cells on nasal polypogenesis[J]. Laryngoscope,2014,124:E151-159.

    [10]

    ZHANG N, VAN ZELE T, PEREZ-NOVO C,et al.Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease[J]. J Allergy Clin Immunol,2008,122:961-968.

    [11]

    BAYAR MULUK N, ARIKAN O K, ATASOY P,et al.The role of platelet-derived growth factor in the pathogenesis of sinonasal polyps:immunohistochemical assessment in epithelial, subepithelial and deep layers of the mucosa[J].Clin Exp Otorhinolaryngol, 2013, 6:152-160.

    [12]

    COSTE A, WANG Q P, ROUDOT-THORAVAL F,et al. Epithelial cell proliferation in nasal polyps could be upregulated by platelet-derived growth factor[J]. Laryngoscope,1996,106:578-583.

    [13]

    SHIN S H,PONIKAU J U, SHERRIS D A,et al. Chronic rhinosinusitis:an enhanced immune response to ubiquitous airborne fungi[J]. J Allergy Clin Immunol, 2004,114:1369-1375.

    [14]

    VOSSBRINCK C R, MADDOX J V, FRIEDMAN S,et al.Ribosomal RNA sequence suggests microsporidia are extremely ancient eukaryotes[J].Nature, 1987,326:411-414.

    [15]

    FEAZEL L M, ROBERTSON C E, RAMAKRISHNAN V R,et al.Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis[J].Laryngoscope, 2012, 122:467-472.

    [16]

    RAMAKRISHNAN V R, FEAZEL L M, ABRASS L J,et al. Prevalence and abundance of Staphylococcus aureus in the middle meatus of patients with chronic rhinosinusitis, nasal polyps, and asthma[J]. Int Forum Allergy Rhinol,2013, 3:267-271.

    [17]

    SACHSE F, BECKER K, VON EIFF C,et al. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro[J]. Allergy,2010,65:1430-1437.

    [18]

    SOYKA M B, WAWRZYNIAK P, EIWEGGER T,et al. Defective epithelial barrier in chronic rhinosinusitis:the regulation of tight junctions by IFN-gamma and IL-4[J].J Allergy Clin Immunol,2012,130:1087-1096.e10.

    [19]

    STRESSMANN F A, ROGERS G B, CHAN S W,et al. Characterization of bacterial community diversity in chronic rhinosinusitis infections using novel culture-independent techniques[J]. Am J Rhinol Allergy,2011,25:e133-140.

    [20]

    VITAL D, HOLZMANN D, BOEHLER A,et al.Chronic infection with Pseudomonas aeruginosa in cystic fibrosis:a risk factor for nasal polyposis after lung transplantation[J]. Transplantation,2013, 95:1548-1553.

    [21]

    CHOI E B, HONG S W, KIM D K,et al. Decreased diversity of nasal microbiota and their secreted extracellular vesicles in patients with chronic rhinosinusitis based on a metagenomic analysis[J]. Allergy,2014, 69:517-526.

    [22]

    BOASE S, FOREMAN A, CLELAND E,et al. The microbiome of chronic rhinosinusitis:culture, molecular diagnostics and biofilm detection[J]. BMC Infect Dis,2013,13:210-210.

    [23]

    BARAC A, PEKMEZOVIC M, SPIRIC V T,et al.Chronic rhinosinusitis:association of recalcitrant nasal polyposis and fungal finding in polyp's single-cellsuspension[J]. Eur Arch Otorhinolaryngol,2015, 272:3727-3734.

    [24]

    LIAO B, HU C Y, LIU T,et al.Respiratory viral infection in the chronic persistent phase of chronic rhinosinusitis[J]. Laryngoscope,2014,124:832-837.

    [25]

    WANG X, ZHANG N, GLORIEUX S,et al. Herpes simplex virus type 1 infection facilitates invasion of Staphylococcus aureus into the nasal mucosa and nasal polyp tissue[J]. PloS One,2012,7:e39875.

    [26]

    MAHDAVINIA M, KESHAVARZIAN A, TOBIN M C,et al. A comprehensive review of the nasal microbiome in chronic rhinosinusitis(CRS)[J]. Clin Exp Allergy,2016,46:21-41.

    [27]

    WHEELER J G, BOGLE M L, SHEMA S J,et al. Impact of dietary yogurt on immune function[J].Am J Med Sci,1997, 313:120-123.

    [28]

    ELLIOTT M K, SISSON J H, WEST W W,et al. Differential in vivo effects of whole cigarette smoke exposure versus cigarette smoke extract on mouse ciliated tracheal epithelium[J].Exp Lung Res,2006, 32:99-118.

    [29]

    KISPERT A, PETRY M, OLBRICH H,et al. Genotype-phenotype correlations in PCD patients carrying DNAH5 mutations[J]. Thorax,2003,58:552-554.

    [30]

    PENNARUN G, ESCUDIER E, CHAPELIN C,et al. Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia[J]. Am J Hum Genet,1999, 65:1508-1519.

    [31]

    SCHWABE G C, HOFFMANN K, LOGES N T,et al. Primary ciliary dyskinesia associated with normal axoneme ultrastructure is caused by DNAH11 mutations[J]. Hum Mutat,2008, 29:289-298.

    [32]

    LOGES N T, OLBRICH H, FENSKE L,et al. DNAI2 mutations cause primary ciliary dyskinesia with defects in the outer dynein arm[J]. Am J Hum Genet,2008, 83:547-558.

    [33]

    OMRAN H, KOBAYASHI D, OLBRICH H,et al. Ktu/PF13 is required for cytoplasmic pre-assembly of axonemal dyneins[J]. Nature,2008,456:611-616.

    [34]

    CASTLEMAN V H, ROMIO L, CHODHARI R,et al. Mutations in radial spoke head protein genes RSPH9 and RSPH4A cause primary ciliary dyskinesia with central-microtubular-pair abnormalities[J]. Am J Hum Genet,2009,84:197-209.

    [35]

    AFZELIUS B A. Asymmetry of cilia and of mice and men[J]. Int J Dev Biol,1999, 43:283-286.

    [36]

    BIEDLINGMAIER J F, TRIFILLIS A. Comparison of CT scan and electron microscopic findings on endoscopically harvested middle turbinates[J]. Otolaryngol Head Neck Surg,1998,118:165-173.

    [37]

    LI Y Y, LI C W, CHAO S S,et al. Impairment of cilia architecture and ciliogenesis in hyperplastic nasal epithelium from nasal polyps[J]. J Allergy Clin Immunol,2014, 134:1282-1292.

    [38]

    LAI Y, CHEN B, SHI J,et al.Inflammation-mediated upregulation of centrosomal protein 110, a negative modulator of ciliogenesis, in patients with chronic rhinosinusitis[J]. J Allergy Clin Immunol,2011,128:1207-1215.e1.

    [39]

    COHEN N A. Sinonasal mucociliary clearance in health and disease[J]. Ann Otol Rhinol Laryngol Suppl,2006, 196:20-26.

    [40]

    HAMMERSCHMIDT S, BERGMANN S,PATERSON G K,et al. Pathogenesis of Streptococcus pneumoniae infections:adaptive immunity, innate immunity, cell biology, virulence factors[M]//MERCER A.Advances in Infectious Diseases.chapter:Community acquired Pneumonia.2007.Switzerland:Birkhäuser Basel,2006:139-181.

    [41]

    FERGUSON J L, MCCAFFREY T V, KERN E B,et al.The effects of sinus bacteria on human ciliated nasal epithelium in vitro[J]. Otolaryngol Head Neck Surg,1988, 98:299-304.

    [42]

    JONES N. The nose and paranasal sinuses physiology and anatomy[J]. Adv Drug Deliv Rev, 2001,51:5-19.

    [43]

    BOGUNIEWICZ M, LEUNG D Y. Atopic dermatitis:a disease of altered skin barrier and immune dysregulation[J]. Immunol Rev,2011,242:233-246.

    [44]

    LIEB T, FREI C W, FROHOCK J I,et al.Prolonged increase in ciliary beat frequency after short-term purinergic stimulation in human airway epithelial cells[J]. J Physiol,2002,538:633-646.

    [45]

    PICHER M, BOUCHER R C. Human airway ecto-adenylate kinase. A mechanism to propagate ATP signaling on airway surfaces[J]. J Biol Chem,2003, 278:11256-11264.

    [46]

    GORREN A C, MAYER B. The versatile and complex enzymology of nitric oxide synthase[J]. Biochemistry(Mosc),1998, 63:734-743.

    [47]

    WANG Y, MARSDEN P A. Nitric oxide synthases:gene structure and regulation[J]. Adv Pharmacol,1995,34:71-90.

    [48]

    PENA-ALTAMIRA E, PETAZZI P, CONTESTABILE A. Nitric oxide control of proliferation in nerve cells and in tumor cells of nervous origin[J]. Curr Pharm Des,2010,16:440-450.

    [49]

    PIFFERI M, BUSH A, MAGGI F,et al. Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia[J]. Eur Respir J,2011,37:572-577.

    [50]

    MULUK N B, ARIKAN O K, ATASOY P, et al.The role of endothelial nitric oxide synthase (eNOS) in the pathogenesis of sinonasal polyps[J]. Eur Rev Med Pharmacol Sci,2014,18:918-929.

    [51]

    ZHAO C Y, WANG X, LIU M,et al.Microarray gene analysis of Toll-like receptor signaling elements in chronic rhinosinusitis with nasal polyps[J].Int Arch Allergy Immunol,2011,156:297-304.

    [52]

    SUN Y, ZHOU B, WANG C,et al. Biofilm formation and Toll-like receptor 2, Toll-like receptor 4, and NF-kappaB expression in sinus tissues of patients with chronic rhinosinusitis[J].Am J Rhinol Allergy,2012,26:104-109.

    [53]

    ZHANG Q, WANG C S, HAN D M,et al. Differential expression of Toll-like receptor pathway genes in chronic rhinosinusitis with or without nasal polyps[J].Acta Otolaryngol,2013,133:165-173.

    [54]

    RAMANATHAN M Jr, LEE W K, DUBIN M G,et al.Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps[J]. Am J Rhinol,2007,21:110-116.

    [55]

    MEYERHOF W, BATRAM C, KUHN C, et al. The molecular receptive ranges of human TAS2R bitter taste receptors[J].Chem Senses,2010, 35:157-170.

    [56]

    LEE R J, COHEN N A. The emerging role of the bitter taste receptor T2R38 in upper respiratory infection and chronic rhinosinusitis[J]. Am J Rhinol Allergy,2013, 27:283-286.

    [57]

    CANNY G, LEVY O. Bactericidal/permeability-increasing protein (BPI) and BPI homologs at mucosal sites[J]. Trends Immunol,2008,29:541-547.

    [58]

    CASADO B, PANNELL L K, IADAROLA P,et al. Identification of human nasal mucous proteins using proteomics[J]. Proteomics, 2005,5:2949-2959.

    [59]

    SESHADRI S, LIN D C, ROSATI M,et al. Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis[J]. Allergy,2012, 67:920-928.

    [60]

    WEI Y, XIA W, YE X,et al. The antimicrobial protein short palate, lung, and nasal epithelium clone 1(SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2014,133:420-428.

    [61]

    GARCIA-CABALLERO A, RASMUSSEN J E, GAILLARD E,et al. SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage[J]. Proc Natl Acad Sci U S A,2009,106:11412-11417.

    [62]

    BERNSTEIN J M, YANKASKAS J R. Increased ion transport in cultured nasal polyp epithelial cells[J]. Arch Otolaryngol Head Neck Surg,1994,120:993-996.

  • 加载中
计量
  • 文章访问数:  72
  • PDF下载数:  82
  • 施引文献:  0
出版历程
收稿日期:  2016-07-13

目录